Alignment Healthcare Inc. (ALHC)
NASDAQ: ALHCHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ALHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.33B
- P/E (TTM)
- 45.50
- Forward P/E
- 11.48
- EPS (TTM)
- $0.14
- Dividend yield
- None
- 52-week range
- 6.01 – 25.12
- Day range
- 6.26 – 6.81
- Volume / Avg
- 5.00M / 8.19M
- Beta
- —
- Shares outstanding
- 209.27M
52-week range
ALHC stock today
On Nov 20, ALHC ended the session at $6.37, shedding $0.13 (2.00%), versus the S&P 500's 3.70% decline. At this level, ALHC sits near the bottom of its 52-week range of $6.01 to $25.12: 74.6% below the high, set on Jul 7, 2026 and 6.0% above the low. ALHC is down 67.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 61.9%.
At 45.5x trailing earnings, Alignment Healthcare trades above the peer-group median of 37.3x. Its forward P/E of 11.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Alignment Healthcare
Company profileAlignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. John E. Kao
- Headquarters
- Orange, CA
- Employees
- 1,849
- IPO year
- 2021
- Website
- alignmenthealth.com
Financial highlights
Full financialsIn fiscal 2025, Alignment Healthcare generated $3.95 billion in revenue, up 46.1% from fiscal 2024, its 6th consecutive year of revenue growth. Alignment Healthcare reported a net loss of $724,000, compared with a loss of $128.0 million a year earlier. Operating margin was 0.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $3.95B | $2.70B | $1.82B | $1.43B | $1.17B |
| Growth | +46.06% | +48.25% | +27.16% | +22.81% | +21.74% |
| Net income | $-724.00K | $-128.03M | $-148.02M | $-149.55M | $-195.29M |
| EPS (diluted) | $0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$10.79+69.39%
- Strong buy 3
- Buy 6
- Hold 6
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $-0.04 vs $-0.04
- Surprise
- 0.00%
ALHC news
All ALHC news- Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - Hagens BermanPR Newswire
- Alignment Healthcare falls 9% amid weakness in Medicare Advantage stocksSeeking Alpha
- ALHC Loss Alert: Alignment Healthcare Investors Investigated for Securities Fraud in Connection with 16% Stock Drop and Potential Misrepresentations about its EBITDAPR Newswire
- ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law FirmPR Newswire
- ALHC Investor Notification: Alignment Healthcare Investigated for Securities Fraud on behalf of Investors with Losses after Inflated EBITDA Leads to 16% Stock DropPR Newswire
- ALHC Shareholder Notice: Alignment Healthcare Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to InvestorsPR Newswire
- Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHCPR Newswire
- Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSSPR Newswire
Alignment Healthcare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LMRILumexa Imaging Holdings Inc. | 14.26 | +1.42% | $1.37B | vs ALHC |
| TRUPTrupanion Inc. | 35.56 | -0.86% | $1.54B | vs ALHC |
| PSNLPersonalis Inc. | 14.27 | -3.06% | $1.55B | vs ALHC |
| FRNMFreenome Inc. | 9.36 | -5.69% | $1.04B | vs ALHC |
| CSTLCastle Biosciences Inc. | 32.86 | -1.63% | $1.01B | vs ALHC |
| FTREFortrea Holdings Inc. | 18.55 | -7.94% | $1.79B | vs ALHC |
| CLOVClover Health Investments Corp. Class A | 3.73 | -1.06% | $2.00B | vs ALHC |
| VCYTVeracyte Inc. | 25.13 | +0.36% | $2.03B | vs ALHC |
Indexes, lists and sector
Alignment Healthcare stock FAQ
What is Alignment Healthcare's stock price today?
ALHC last traded at $6.37 as of Nov 20, 4:00 PM EST, down 2.00% on the day. Prices are delayed at least 15 minutes.
What is ALHC's P/E ratio?
ALHC trades at a trailing P/E ratio of 45.50 and a forward P/E of 11.48, compared with a median of 37.3 for its closest peers.
Who is Alignment Healthcare's CEO?
Mr. John E. Kao is the chief executive officer of Alignment Healthcare Inc., which has about 1,849 employees.
What is the ALHC 52-week high?
The 52-week high for ALHC is $25.12 and the 52-week low is $6.01. The stock is currently 74.6% below its high.